Janumet XR is a prescription tablet that combines two diabetes medications into a single once-daily pill to lower blood sugar in adults with type 2 diabetes. The two active ingredients are sitagliptin and metformin extended-release, which work through different mechanisms to control glucose levels more effectively than either drug alone.
How the Two Ingredients Work
Sitagliptin and metformin attack high blood sugar from different angles, which is why combining them in one tablet can be more effective than taking just one.
Sitagliptin belongs to a class called DPP-4 inhibitors. After you eat, your gut releases hormones that signal your pancreas to produce insulin. An enzyme called DPP-4 normally breaks down those hormones quickly. Sitagliptin blocks that enzyme, letting the hormones stick around longer so your body produces more insulin when it’s needed and your liver releases less sugar into the bloodstream.
Metformin is a biguanide, one of the oldest and most widely used diabetes drugs. It works primarily by reducing the amount of glucose your liver produces and by helping your muscles and tissues absorb sugar from the blood more efficiently. The extended-release (XR) form dissolves slowly, which means it releases the medication gradually throughout the day rather than all at once.
How to Take It
Janumet XR is taken once a day with a meal. The FDA labeling recommends taking it with your evening meal in particular, which helps reduce the chance of stomach upset. The tablet needs to be swallowed whole, not crushed, split, or chewed, because breaking the extended-release shell would release the metformin too quickly.
Common Side Effects
The most frequently reported side effects in clinical trials were digestive. In a 24-week study, diarrhea occurred in about 7.5% of people taking the combination (compared to 4% on placebo), nausea in about 4.8%, and abdominal pain in about 3%. Upper respiratory tract infections (6.2%) and headache (5.9%) were also more common than with placebo.
These stomach-related side effects are largely driven by the metformin component. Taking the medication with food helps, and the extended-release formulation itself tends to cause fewer GI problems than immediate-release metformin because the drug enters your system more gradually.
Low blood sugar (hypoglycemia) is not common with Janumet XR on its own. However, the risk increases significantly if you also take a sulfonylurea or insulin. In trials where sitagliptin and metformin were added to a sulfonylurea, hypoglycemia occurred in about 16% of patients, compared to less than 1% without the added medication.
The “Ghost Tablet” in Your Stool
One thing that catches many people off guard: you may notice what looks like a whole tablet in your stool. This is the empty outer shell of the extended-release tablet. The medication has already been absorbed. These so-called ghost tablets appear in up to 54% of people taking metformin XR formulations. They show up as soft, hydrated masses and are completely harmless. Your body got the full dose of the drug even though the shell passed through intact.
Serious Risks to Know About
The most significant safety concern with any metformin-containing medication is a rare but serious condition called lactic acidosis, where lactic acid builds up in the blood faster than the body can clear it. This is uncommon in people with normal kidney and liver function, but certain situations raise the risk substantially: kidney problems (since metformin is cleared through the kidneys), liver failure, heart failure, severe dehydration, heavy alcohol use, or any condition that reduces oxygen delivery to tissues.
Early symptoms of lactic acidosis can look a lot like ordinary side effects: nausea, vomiting, stomach pain, and diarrhea. What distinguishes it are signs like unusual fatigue, dizziness, feeling cold, rapid or difficult breathing, and muscle pain. More severe cases can lead to confusion or loss of consciousness. Because the early symptoms overlap with common metformin side effects, it’s important to pay attention if those symptoms feel different from your baseline or come on suddenly.
The sitagliptin component carries an FDA warning about pancreatitis. Cases of acute pancreatitis have been reported in post-marketing surveillance, though an FDA review did not find a definitively increased risk. People with a history of pancreatitis should be aware of this potential concern. Symptoms of pancreatitis include severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting.
Kidney Function Matters
Because metformin is almost entirely cleared by the kidneys, your kidney function determines whether Janumet XR is safe for you and at what dose. Your doctor will check your kidney function (typically measured by a blood test called eGFR) before starting the medication and periodically while you’re on it. If kidney function declines enough, the metformin component can accumulate to unsafe levels, so the dose may need to be reduced or the medication stopped.
How Janumet XR Differs From Janumet
Regular Janumet contains immediate-release metformin and is taken twice daily. Janumet XR uses extended-release metformin, allowing for once-daily dosing. The sitagliptin component is the same in both. The practical difference is convenience and potentially fewer stomach side effects with the XR version, since the metformin is absorbed more slowly. Your doctor may switch you from twice-daily Janumet to once-daily Janumet XR if the total daily doses of both ingredients match up.